Unlocking the Potential of Membrane Protein Targets in Drug Discovery: A Comprehensive Guide
Membrane proteins, despite comprising only 25% of the human genome's proteins, account for over half of all therapeutic targets. This notable overrepresentation is due to their location at the beginning of many signaling cascades and their presence on the cell surface, making them accessible to biologic and small-molecule medications. However, working with membrane proteins presents unique challenges that can hinder drug discovery and development.
Overcoming Challenges with Membrane Proteins
Low Native Expression
Membrane proteins are less common than soluble proteins due to their limited 2D location within membranes. Each membrane protein may also be expressed exclusively in a specific tissue or cell type, further complicating their study. To address this, heterologous expression systems such as E. coli, insect cells, or mammalian expression systems can be employed to increase functional expression levels. Careful construct design and screening of multiple constructs and orthologs can significantly improve success rates.
Low Stability, Purity, and Activity
Membrane proteins' natural environment in phospholipid bilayers makes them susceptible to unfolding or aggregation when extracted with detergents. To mitigate this, careful detergent selection is crucial for maintaining protein folding and activity. Stabilized constructs and point mutations can also enhance yields and stability. Membrane mimetics like SMA, amphipols, peptidiscs, and nanodiscs provide an alternative for long-term stability without detergents. Additionally, avoiding protein isolation by performing activity assays in overexpressed systems or relevant cell types can minimize interference.
Challenges with Structural Characterization
Membrane proteins' flexibility, conformational heterogeneity, and instability over time make structural characterization difficult. Well-ordered crystals are often challenging to obtain for X-ray crystallography. However, suitable construct design, careful purification, and detailed biophysical characterization can improve the chances of structure identification. Cryo-EM is a valuable technique for determining structures without the need for ordered crystals, especially for large, flexible, full-length membrane proteins and multi-subunit complexes.
Concept Life Sciences: Supporting Membrane Protein Discovery
Concept Life Sciences, a leading contract research organization, offers comprehensive support for membrane protein discovery. With extensive experience in expressing and purifying these challenging targets, they provide construct design, protein production in various systems, and purification using detergents and membrane mimetics. Their services also include QC, biophysical characterization, binding assays, cryo-EM, and crystallography.
The company's commitment to scientific excellence and customer service has helped numerous clients advance their drugs to the clinic. With a passionate team of scientists and state-of-the-art facilities, Concept Life Sciences is well-equipped to tackle the complexities of membrane protein research, driving innovation in drug discovery and development.
In conclusion, membrane proteins present unique challenges in drug discovery, but with the right approaches and expertise, these obstacles can be overcome. Concept Life Sciences is at the forefront of this field, providing invaluable support to researchers and contributing to the advancement of therapeutic interventions.
